Article Details

Mereo BioPharma Group (NASDAQ:MREO) Lowered to Sell Rating by Wall Street Zen

Retrieved on: 2025-07-19 05:17:15

Tags for this article:

Click the tags to see associated articles and topics

Mereo BioPharma Group (NASDAQ:MREO) Lowered to Sell Rating by Wall Street Zen. View article details on hiswai:

Excerpt

Wall Street Zen cut Mereo BioPharma Group from a "hold" rating to a "sell" rating in a research report on Friday.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo